rs147788838
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001009944.3(PKD1):c.8713G>A(p.Val2905Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00311 in 1,605,844 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001009944.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKD1 | NM_001009944.3 | c.8713G>A | p.Val2905Ile | missense_variant | Exon 23 of 46 | ENST00000262304.9 | NP_001009944.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00179 AC: 273AN: 152166Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.00170 AC: 407AN: 238784Hom.: 1 AF XY: 0.00169 AC XY: 222AN XY: 131708
GnomAD4 exome AF: 0.00324 AC: 4714AN: 1453560Hom.: 18 Cov.: 34 AF XY: 0.00312 AC XY: 2259AN XY: 723358
GnomAD4 genome AF: 0.00179 AC: 273AN: 152284Hom.: 2 Cov.: 32 AF XY: 0.00163 AC XY: 121AN XY: 74460
ClinVar
Submissions by phenotype
not provided Benign:5
- -
- -
- -
- -
PKD1: BP4, BS2 -
Polycystic kidney disease, adult type Uncertain:1
The PKD1 c.8713G>A; p.Val2905Ile variant (rs147788838) is reported in the literature as a benign polymorphism (Rossetti 2001). This variant is also reported in ClinVar (Variation ID: 257028), and is found in the general population with an overall allele frequency of 0.17% (457/270176 alleles, including a single homozygote) in the Genome Aggregation Database. The valine at codon 2905 is highly conserved, but computational analyses (SIFT, PolyPhen-2) predict that this variant is tolerated. However, given the lack of clinical and functional data, the significance of the p.Val2905Ile variant is uncertain at this time. References: Rossetti S et al. Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications. Am J Hum Genet. 2001 Jan;68(1):46-63. -
not specified Benign:1
- -
Polycystic kidney disease Benign:1
The PKD1 p.Val2905Ile variant was identified as a polymorphism in the literature in a cohort of 131 patients with ADPKD however frequency information was not reported (Rossetti 2001). The variant was also identified in dbSNP (ID: rs147788838) as “NA”, and the ADPKD Mutation Database (classification “likely neutral”) but not in Clinvitae, ClinVar, GeneInsight COGR, PKD1-LOVD, or PKD1-LOVD 3.0 databases. The variant was identified in the 1000 Genomes Project in 7 of 5000 chromosomes (frequency: 0.0014); HAPMAP populations: AMR in 1 of 694 chromosomes (frequency: 0.0014), EUR in 5 of 1006 chromosomes (frequency: 0.005), and AFR in 1 of 1322 chromosomes (frequency: 0.0008); the NHLBI GO Exome Sequencing Project in 22 of 8316 European American alleles and in 4 of 4202 African American alleles; and in the Exome Aggregation Consortium database (March 14, 2016): 30 of 11356 alleles (frequency: 0.0026) in a Latino population, in 129 of 61572 alleles (1 homozygous, frequency: 0.0021) from a European (Non-Finnish) population, in 1 of 8386 alleles (frequency: 0.0001) from a East Asian population, in 6 of 8310 alleles (frequency: 0.0007) from an African population, in 3 of 16374 alleles (frequency: 0.0002) from a population of South Asian and in 2 of 6556 alleles (frequency: 0.0003) from a population of European (Finnish) individuals; it was not seen in “Other” population. The p.Val2905 residue is not conserved in mammals and the variant amino acid Ile is present in dog, increasing the likelihood that this variant does not have clinical significance. Computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. This variant was identified in our laboratory in one individual with ADPKD and a co-occurring pathogenic variant in PKD1 (c.160_166dup, p.Leu56ProfsX60), increasing the likelihood this variant does not have clinical significance. In summary, based on the above information this variant is classified as likely benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at